» Articles » PMID: 25644601

TGF-β/Smad Signaling Through DOCK4 Facilitates Lung Adenocarcinoma Metastasis

Overview
Journal Genes Dev
Specialty Molecular Biology
Date 2015 Feb 4
PMID 25644601
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

The mechanisms by which TGF-β promotes lung adenocarcinoma (ADC) metastasis are largely unknown. Here, we report that in lung ADC cells, TGF-β potently induces expression of DOCK4, but not other DOCK family members, via the Smad pathway and that DOCK4 induction mediates TGF-β's prometastatic effects by enhancing tumor cell extravasation. TGF-β-induced DOCK4 stimulates lung ADC cell protrusion, motility, and invasion without affecting epithelial-to-mesenchymal transition. These processes, which are fundamental to tumor cell extravasation, are driven by DOCK4-mediated Rac1 activation, unveiling a novel link between TGF-β and Rac1. Thus, our findings uncover the atypical Rac1 activator DOCK4 as a key component of the TGF-β/Smad pathway that promotes lung ADC cell extravasation and metastasis.

Citing Articles

Effects of Confined Microenvironments with Protein Coating, Nanotopography, and TGF-β Inhibitor on Nasopharyngeal Carcinoma Cell Migration through Channels.

Hong X, Xu Y, Pang S J Funct Biomater. 2024; 15(9).

PMID: 39330238 PMC: 11433299. DOI: 10.3390/jfb15090263.


is required for the maintenance of cochlear hair cells and hearing function.

Hong G, Fu X, Qi J, Shao B, Han X, Fang Y Fundam Res. 2024; 3(4):557-569.

PMID: 38933554 PMC: 11197514. DOI: 10.1016/j.fmre.2022.04.016.


Brain endothelial cells promote breast cancer cell extravasation to the brain via EGFR-DOCK4-RAC1 signalling.

Galloni C, Egnuni T, Mohajerani S, Ye J, Mittnacht S, Speirs V Commun Biol. 2024; 7(1):602.

PMID: 38762624 PMC: 11102446. DOI: 10.1038/s42003-024-06200-x.


Multi-omics identification of GPCR gene features in lung adenocarcinoma based on multiple machine learning combinations.

Xie Y, Pan X, Wang Z, Ma H, Xu W, Huang H J Cancer. 2024; 15(3):776-795.

PMID: 38213730 PMC: 10777041. DOI: 10.7150/jca.90990.


DOCK4 is a Novel Prognostic Biomarker and Correlated with Immune Infiltrates in Colon Adenocarcinoma.

Xie X, Lu Y, Wang B, Yin X, Chen J Comb Chem High Throughput Screen. 2023; 27(8):1119-1130.

PMID: 37702239 DOI: 10.2174/1386207326666230912094101.


References
1.
Nemunaitis J, Nemunaitis M, Senzer N, Snitz P, Bedell C, Kumar P . Phase II trial of Belagenpumatucel-L, a TGF-beta2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients. Cancer Gene Ther. 2009; 16(8):620-4. DOI: 10.1038/cgt.2009.15. View

2.
Gaunt S, George M, Paul Y . Direct activation of a mouse Hoxd11 axial expression enhancer by Gdf11/Smad signalling. Dev Biol. 2013; 383(1):52-60. DOI: 10.1016/j.ydbio.2013.08.025. View

3.
Reymond N, Borda DAgua B, Ridley A . Crossing the endothelial barrier during metastasis. Nat Rev Cancer. 2013; 13(12):858-70. DOI: 10.1038/nrc3628. View

4.
Hasegawa Y, Takanashi S, Kanehira Y, Tsushima T, Imai T, Okumura K . Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma. Cancer. 2001; 91(5):964-71. View

5.
Cote J, Vuori K . Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity. J Cell Sci. 2002; 115(Pt 24):4901-13. DOI: 10.1242/jcs.00219. View